Nova Patents
AT338757T

Imidazonaphthyridines and their use in inducing cytokine biosynthesis

Abstract

Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.

Term

Term ended

Expired 11 December 2018, 7.8 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

113 members in 28 offices

This recordMember, by publication datePriority claim18 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
6927697United States of AmericaP

Members113

Family members, oldest first
DocumentOfficeKind
CA2311456A1CanadaA1
WO9929693A1World Intellectual Property Organization (WIPO)A1
AU1912399AAustraliaA
NO20002663D0NorwayD0
NO20002663LNorwayL
NO20035718LNorwayL
BR9814275ABrazilA
EP1040112A1European Patent Office (EPO)A1
CN1284957AChinaA
US6194425B1United States of AmericaB1
SK8352000A3SlovakiaA3
PL341159A1PolandA1
KR20010033016ARepublic of KoreaA
IL136556D0IsraelD0
HRP20000363A2CroatiaA2
TR200001705T2TürkiyeT2
EE200000349AEstoniaA
JP2001525411AJapanA
HU0101155A2HungaryA2
HUP0101155A2HungaryA2
NZ504776ANew ZealandA
HU0101155A3HungaryA3
HUP0101155A3HungaryA3
AU753864B2AustraliaB2
US2002173653A1United States of AmericaA1
US2002173654A1United States of AmericaA1
US6514985B1United States of AmericaB1
US6518280B2United States of AmericaB2
US2003083500A1United States of AmericaA1
US2003096998A1United States of AmericaA1
US6624172B2United States of AmericaB2
US6638944B2United States of AmericaB2
US2003212093A1United States of AmericaA1
NO20035718D0NorwayD0
NO20035719D0NorwayD0
US2004006098A1United States of AmericaA1
RU2221798C2Russian FederationC2
KR20040011532ARepublic of KoreaA
KR20040011533ARepublic of KoreaA
US2004023932A1United States of AmericaA1
US6693113B2United States of AmericaB2
US6699878B2United States of AmericaB2
NO316687B1NorwayB1
US6747040B2United States of AmericaB2
EE04314B1EstoniaB1
CN1154647CChinaC
UA67760C2UkraineC2
EP1040112B1European Patent Office (EPO)B1
US6797716B2United States of AmericaB2
US2004204436A1United States of AmericaA1
AT277046TAustriaT
ATE277046T1AustriaT1
DE69826518D1GermanyD1
WO9929693A8World Intellectual Property Organization (WIPO)A8
DK1040112T3DenmarkT3
PT1040112EPortugalE
RU2003126259ARussian FederationA
SI1040112T1SloveniaT1
EP1512685A1European Patent Office (EPO)A1
EP1512686A1European Patent Office (EPO)A1
RU2003126258ARussian FederationA
ES2227902T3SpainT3
US6894165B2United States of AmericaB2
US2005107421A1United States of AmericaA1
HK1070655A1Hong Kong, ChinaA1
HRP20000363B1CroatiaB1
DE69826518T2GermanyT2
US6949646B2United States of AmericaB2
US2005288320A1United States of AmericaA1
KR100563175B1Republic of KoreaB1
JP2006083188AJapanA
US7038051B2United States of AmericaB2
US2006128674A1United States of AmericaA1
EP1512685B1European Patent Office (EPO)B1
AT333456TAustriaT
ATE333456T1AustriaT1
DE69835309D1GermanyD1
EP1512686B1European Patent Office (EPO)B1
AT338757TThis recordAustriaT
ATE338757T1AustriaT1
DE69835844D1GermanyD1
KR100642702B1Republic of KoreaB1
KR100642703B1Republic of KoreaB1
DK1512685T3DenmarkT3
PT1512685EPortugalE
SI1512685T1SloveniaT1
DK1512686T3DenmarkT3
PT1512686EPortugalE
SI1512686T1SloveniaT1
IL136556AIsraelA
PL193915B1PolandB1
ES2270249T3SpainT3
DE69835844T2GermanyT2
ES2273138T3SpainT3
DE69835309T2GermanyT2
US2007167481A1United States of AmericaA1
SK285872B6SlovakiaB6
JP2007262093AJapanA
IL178091AIsraelA
IL178092AIsraelA
Showing 100 of 113